Abstract WP327: Altered Bone Marrow Microenvironment Impacts Endothelial Precursor Cell Development and Egress in Mice With Type 2 Diabetes
Hongxia Zhang,Kailin Yu,Yuya Kato,Jaime Falcone-Juengert,Jialing Liu
DOI: https://doi.org/10.1161/str.55.suppl_1.wp327
IF: 10.17
2024-02-03
Stroke
Abstract:Stroke, Volume 55, Issue Suppl_1, Page AWP327-AWP327, February 1, 2024. Endothelial precursor cells (EPCs) are vital contributors to angiogenesis, a crucial process in tissue repair and functional recovery after ischemic stroke. However, in the context of Type 2 Diabetes Mellitus (T2DM), angiogenesis is compromised, particularly after ischemic stroke. The mechanisms underlying the impacts of T2DM on EPC dynamics in the bone marrow (BM), as well as its repercussions on functional recovery post-stroke, remain incompletely understood. We found that the EPC populations were significantly diminished in the BM of diabetic mice compared to control mice prior to stroke by immunofluorescence staining (IF). Interestingly, the number of EPC was not significantly changed in the BM of diabetic mice after stroke, in contrast to the reduction seen in the control mice, suggesting an inherent impairment of EPC production and migration in the diabetic BM milieu. Consistent with this finding, VEGF, a critical factor for EPC proliferation and migration, was found to be increased in the BM in the control mice but reduced in the diabetic mice after ischemic stroke. There was also an overall reduction of CD115 and Ly6G expression in the BM of diabetic mice, indicative of an altered microenvironment for hematopoiesis that could further affect EPC dynamics. Single-cell RNA sequencing of cells revealed the presence of hematopoietic precursor cells (HPC), monocytes, granulocytes, and macrophages among the clustered cell populations. Enrichment analysis unveiled pathways associated with mitotic DNA replication, myeloid cell differentiation, and leukocyte migration among the differentially expressed genes in HPC between diabetic and control BM. Strikingly, genes linked to the angiogenesis and endothelial cell migration were also down regulated in T2DM BM, potentially contributing to the impaired angiogenic response observed in T2DM after stroke. These findings underscore the intricate interplay among T2DM, EPC function, angiogenesis, and post-stroke recovery. The identification of disrupted pathways in the BM environment provides valuable insights into the compromised angiogenic response observed in diabetes and novel targets for therapeutic interventions in improving stroke outcomes in patients with T2DM.
peripheral vascular disease,clinical neurology